{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Amyotrophic lateral sclerosis or motor neuron disease",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_riluzole",
          "name": "Riluzole"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_edaravone",
          "name": "Edaravone"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_nerinetide",
          "name": "Nerinetide"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_tirasemtiv",
          "name": "Tirasemtiv"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_masitinib",
          "name": "Masitinib"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_tofersen",
          "name": "Tofersen"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_brensocatib",
          "name": "Brensocatib"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_girasole",
          "name": "Girasole"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_lacosamide",
          "name": "Lacosamide"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_dexpramipexole",
          "name": "Dexpramipexole"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_selegiline",
          "name": "Selegiline"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_sodium_phenylbutyrate",
          "name": "Sodium Phenylbutyrate"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 1
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_riluzole",
          "type": "Drug",
          "label": "Riluzole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_edaravone",
          "type": "Drug",
          "label": "Edaravone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_nerinetide",
          "type": "Drug",
          "label": "Nerinetide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tirasemtiv",
          "type": "Drug",
          "label": "Tirasemtiv",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_masitinib",
          "type": "Drug",
          "label": "Masitinib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_tofersen",
          "type": "Drug",
          "label": "Tofersen",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_brensocatib",
          "type": "Drug",
          "label": "Brensocatib",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_girasole",
          "type": "Drug",
          "label": "Girasole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_lacosamide",
          "type": "Drug",
          "label": "Lacosamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_dexpramipexole",
          "type": "Drug",
          "label": "Dexpramipexole",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_selegiline",
          "type": "Drug",
          "label": "Selegiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sodium_phenylbutyrate",
          "type": "Drug",
          "label": "Sodium Phenylbutyrate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_glutamate",
          "type": "Target",
          "label": "Glutamate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "target_caspr",
          "type": "Target",
          "label": "CASPR",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "pathway_neuroprotection",
          "type": "Pathway",
          "label": "Neuroprotection Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "disease_amyotrophic_lateral_sclerosis",
          "type": "Disease",
          "label": "Amyotrophic Lateral Sclerosis",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_riluzole",
          "target": "target_glutamate",
          "relation": "inhibits",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "有研究表明 Riluzole 通过抑制谷氨酸释放保护神经元"
        },
        {
          "source": "drug_edaravone",
          "target": "target_caspr",
          "relation": "acts_on",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "临床数据支持 Edaravone 可改善神经元功能"
        },
        {
          "source": "target_glutamate",
          "target": "pathway_neuroprotection",
          "relation": "involved_in",
          "weight": 0.78,
          "agent": "Proponent",
          "rationale": "谷氨酸信号通路在神经保护中起重要作用"
        },
        {
          "source": "target_caspr",
          "target": "pathway_neuroprotection",
          "relation": "involved_in",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "CASPR 参与髓鞘形成，对神经保护通路有影响"
        },
        {
          "source": "pathway_neuroprotection",
          "target": "disease_amyotrophic_lateral_sclerosis",
          "relation": "involved_in",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "神经保护通路与肌萎缩侧索硬化症的发生发展相关"
        },
        {
          "source": "drug_riluzole",
          "target": "H1",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "支持 Riluzole 用于 ALS 治疗"
        },
        {
          "source": "drug_edaravone",
          "target": "H2",
          "relation": "supports",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "支撑 Edaravone 在 ALS 方面的疗效"
        },
        {
          "source": "drug_nerinetide",
          "target": "H3",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Nerinetide 显示出改善神经保护的潜力"
        },
        {
          "source": "drug_tirasemtiv",
          "target": "H4",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Tirasemtiv 被评估用于 ALS 治疗"
        },
        {
          "source": "drug_masitinib",
          "target": "H5",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Masitinib 显示出对 ALS 的潜在益处"
        },
        {
          "source": "drug_tofersen",
          "target": "H6",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "Tofersen 作为 SOD1 抑制剂被应用于 ALS"
        },
        {
          "source": "drug_brensocatib",
          "target": "H7",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "Brensocatib 的潜在益处需要进一步验证"
        },
        {
          "source": "drug_girasole",
          "target": "H8",
          "relation": "supports",
          "weight": 0.45,
          "agent": "Proponent",
          "rationale": "Girasole 的临床效果尚待评估"
        },
        {
          "source": "drug_lacosamide",
          "target": "H9",
          "relation": "supports",
          "weight": 0.4,
          "agent": "Proponent",
          "rationale": "Lacosamide 对 ALS 的疗效存在争议"
        },
        {
          "source": "drug_dexpramipexole",
          "target": "H10",
          "relation": "supports",
          "weight": 0.35,
          "agent": "Proponent",
          "rationale": "Dexpramipexole 在 ALS 中的作用仍需更多证据支持"
        },
        {
          "source": "drug_selegiline",
          "target": "H11",
          "relation": "supports",
          "weight": 0.3,
          "agent": "Proponent",
          "rationale": "Selegiline 的疗效尚未得到完全证实"
        },
        {
          "source": "drug_sodium_phenylbutyrate",
          "target": "H12",
          "relation": "supports",
          "weight": 0.25,
          "agent": "Proponent",
          "rationale": "Sodium Phenylbutyrate 的有效性需要进一步研究"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "Riluzole 和 Edaravone 在神经保护和ALS治疗中显示出显著作用",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "多种候选药物可能在 ALS 治疗中发挥作用",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "假设候选药物能有效达到靶器官并发挥作用"
    ],
    "uncertainties": [
      "每个药物的长期疗效和安全性尚需临床数据验证"
    ],
    "next_focus_for_pi": [
      "需要进一步确认两条路径的独立性，以及对其他候选药物的验证"
    ]
  }
}